Labshake search
Citations for BioLegend :
301 - 350 of 1059 citations for Zinc Finger Protein 50 ZNF50 Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... CD137 APC (1:50, Biolegend, Cat# 309810), and OX40 PE-Cy7 (1:50 ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 ng/mL of BMP4 (Biolegend 94073), and 20 ng/mL of bFGF (Peprotech ...
-
bioRxiv - Immunology 2023Quote: ... and CD11b-BV711 (1:50; ICRF44, BioLegend). DAPI (Life Technologies ...
-
bioRxiv - Immunology 2023Quote: ... CXCR1-PerCP (1:50; 8F1/CXCR1, BioLegend), CD11b(act)-PECy7 (1:100 ...
-
bioRxiv - Immunology 2023Quote: ... and CD10-BV510 (1:50; HI10a, BioLegend). For quantification of BM aspirate cell distribution and CXCR1/CXCR2 expression ...
-
bioRxiv - Neuroscience 2023Quote: ... clone 6E10 (Biolegend, Cat# 803001, 1:50), rabbit anti-Tau antibody pSer202/pThr205 ...
-
bioRxiv - Neuroscience 2023Quote: ... clone 429 (MVCAM.A) (BioLegend 105728, 1:50), rat Ultra-LEAF™ purified anti-mouse CD54 antibody ...
-
bioRxiv - Immunology 2023Quote: ... CD27 BV605 (O323, 1:50, BioLegend, RRID:AB_11204431), CD20 APC-Cy7 (2H7 ...
-
bioRxiv - Bioengineering 2023Quote: ... and 50 ng/mL IL-18 (Biolegend) (51 ...
-
bioRxiv - Developmental Biology 2023Quote: ... or Epcam-BV421 (Biolegend, 118225, 1/50), Aqua Zombie (BioLegend ...
-
bioRxiv - Cancer Biology 2023Quote: ... EPCAM-AF488 (Biolegend, clone 9C4, 1:50), CD49f-PE/Cy7 (Biolegend ...
-
bioRxiv - Neuroscience 2023Quote: ... clone 6E10 (Biolegend, Cat# 803001, 1:50) overnight at 4°C ...
-
bioRxiv - Neuroscience 2023Quote: ... BV510 anti-CD4 (1:50, BioLegend, 100449), BUV570 anti-CD44 (1:100 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD45-BV510(1:50, clone HI30; Biolegend), CD235a-PE-Cy7(1:50 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD34-AF700 (1:50, clone 581; Biolegend), CD117-PE-CF594 (1:50 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD34-AF700 (1:50, clone 581; Biolegend), CD117-PE-CF594 (1:50 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD271-PE (1:50, clone ME20.4; Biolegend), CD105-APC (1:50 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and CD235a (1:50, clone HIR2, Biolegend) followed by depletion using magnetic anti-biotin beads (20Lµl per 107 cells ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD51-PE (1:50, RMV-7, Biolegend), Sca1-PacificBlue (1:100 ...
-
bioRxiv - Cancer Biology 2023Quote: ... CD34-AF700 (1:50, clone 581; Biolegend). For counting of AML cells ...
-
bioRxiv - Bioengineering 2023Quote: ... CD19-BV786 (1:50, clone HIB19, Biolegend), CD123-BV711 (1:20 ...
-
bioRxiv - Bioengineering 2023Quote: ... CD27-BV650 (1:50, clone O323, Biolegend), CD3-BV605 (1:50 ...
-
bioRxiv - Bioengineering 2023Quote: ... CD3-BV605 (1:50, clone OKT3, Biolegend), CD14-BV510 (1:25 ...
-
bioRxiv - Bioengineering 2023Quote: ... CD45RA-APC (1:50, clone HI100, Biolegend), HLA-A/B/C-BV605 (1:20 ...
-
bioRxiv - Immunology 2023Quote: ... 50 ng/mL IL-27 (577402, BioLegend), 10 ng/mL IFNβ (581302 ...
-
bioRxiv - Cell Biology 2023Quote: ... IgG1 control MG1-45 (1:50 Biolegend). Secondary antibodies were allophycocyanin (APC)-conjugated monoclonal rat anti-mouse IgG1 RMG1–1 (Biolegend 1:50 ...
-
bioRxiv - Cell Biology 2023Quote: ... HIM6 (basigin) (Biolegend [1:50 flow cytometry), IgG1 control MG1-45 (1:50 Biolegend) ...
-
bioRxiv - Cancer Biology 2023Quote: ... NKp46 (Biolegend cat. no 137611; 1:50), and PD1 (Biolegend cat ...
-
bioRxiv - Physiology 2023Quote: ... rat anti-CD45 (1:50, 103102, Biolegend), rabbit anti-CD68 (1:100 ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50 ng/ml rhGM-CSF (Biolegend) for 6 days with half media changes on day 3 ...
-
bioRxiv - Immunology 2024Quote: ... 50 ng/mL anti-CD45RA-BV421 (Biolegend) and 40 ng/mL anti-CLEC12A-PE (eBioscience ...
-
bioRxiv - Immunology 2022Quote: ... anti-granzyme B PE (1:50; clone QA16A02) and anti-TNFα BV711 (1:50; clone MP6-XT22) from BioLegend in permeabilization buffer at 4°C for 30 min ...
-
bioRxiv - Cell Biology 2020Quote: ... The cells were incubated with primary antibodies diluted in blocking solution: 5% Normal Goat Serum (Biolegend, 927502), or 0.2% (w/v ...
-
bioRxiv - Cell Biology 2020Quote: 100µl bone marrow were blocked with 2µl Fc Receptor Blocking Solution (Human TruStain FcX™, (422301, Biolegend) for 10 minutes at room temperature ...
-
bioRxiv - Cell Biology 2019Quote: ... cells were then incubated for 10 minutes at 4°C in human Fc Blocking reagent (FcX, BioLegend). Cells were incubated at 4°C for a further 30 minutes with 0.5µg of TotalSeq™-A (Biolegend ...
-
bioRxiv - Immunology 2019Quote: ... then incubated with 0.5 ml of human TruStain FcX Fc receptor blocking solution (Biolegend, San Diego, CA) for 10 minutes.
-
bioRxiv - Cancer Biology 2020Quote: ... LPS stimulation was performed in the presence of blocking anti-IL-6 antibody or control IgG (Biolegend), at a concentration of 1ug/mL.
-
bioRxiv - Bioengineering 2021Quote: ... which were incubated overnight at 4 °C with primary antibodies diluted 1:5,000 in blocking buffer (BioLegend Way ...
-
bioRxiv - Cell Biology 2021Quote: ... cells were then incubated for 10 minutes at 4°C in human Fc Blocking reagent (FcX, BioLegend). Cells were incubated at 4°C for a further 30 minutes with 0.5μg of TotalSeq-A (Biolegend ...
-
bioRxiv - Cell Biology 2022Quote: ... The cells were incubated with antibodies diluted in a blocking solution of 5% Normal Goat Serum (BioLegend) in PBS ...
-
bioRxiv - Cancer Biology 2022Quote: ... Approximately 1×106 cells were aliquoted in 5 ml tubes and incubated with Fc Blocking antibody (Biolegend). Antibodies used for immune profiling are detailed in Supplementary Table 1 ...
-
bioRxiv - Cancer Biology 2020Quote: ... 100,000–500,000 single cells of breast tumours were suspended in 100μl staining buffer (2% BSA, 0.01% Tween in PBS) before adding 10µl Fc-blocking reagent (FcX, BioLegend). and incubating during 10 min on ice ...
-
bioRxiv - Cell Biology 2021Quote: ... were blocked with 5ul Human TruStain FcX™ Blocking Reagent for 10 minutes at 4°C (BioLegend). 1ug of each TotalSeq™-A antibody was added to the cell suspension ...
-
bioRxiv - Immunology 2022Quote: ... in the presence or absence of a mouse anti-human PD1 (2 μg/mL) blocking antibody (Biolegend). CD4+ T-cells were identified using a mouse-anti human CD4 (OKT4 clone ...
-
bioRxiv - Cancer Biology 2022Quote: ... and cells were incubated with a blocking solution containing mouse TruStain FcX (Biolegend, San Diego, CA; #101319) before antibody staining ...
-
bioRxiv - Immunology 2023Quote: ... Cells were resuspended in semi-facs buffer in the presence of Fc receptor blocking antibody (BioLegend, 101302) and stained with antibodies at a 1:200 dilution with the myeloid or lymphoid antibody cocktails ...
-
bioRxiv - Cancer Biology 2023Quote: ... Cells were then washed and incubated with the FcR-blocking anti-murine CD16/32 antibody (Biolegend #101301) at 4 °C for 10 minutes ...
-
bioRxiv - Genomics 2023Quote: ... The PBMC pellet was resuspended and cells were stained with Human TruStain FcX Fc Blocking Reagent (BioLegend) for 10 min at 4°C and then with fixable viability dye DAPI (Merck) ...
-
bioRxiv - Immunology 2024Quote: ... Cells were washed once and resuspended in 100μl blocking buffer (2%FBS and 1% FcX (BioLegend, 422302) in PBS ...
-
bioRxiv - Cancer Biology 2024Quote: ... Single-cell suspensions of tumor tissues were blocked with 1.5 µg TruStain FcX PLUS Blocking Reagent (Biolegend) for 10 min at room temperature then stained with Live/Dead dye (Zombie Aqua ...